$CUE

$18.45 -$0.21 (1.13%) Close

$CUE Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 7.3M shares outstanding

Who owns CUE?

By type of holder

Institutions 22.6% Insiders 14.0% Everyone else 63.4%

Concentration Top 10 holders own 20.8%

Bleichroeder LP 5.1% · Vanguard Capital Management LLC 2.2%

Institutional ownership

22.6%

-77.4 pts vs last qtr

Institutional holders

-8 vs last qtr

Net shares bought

−19.8M

by institutions in Q2 2026

New / sold out

14 / 22

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Driehaus Capital Management LLC NEW +292.1K
Ikarian Capital, LLC NEW +104.4K

Biggest sellers in Q2 2026

Bleichroeder LP −6.4M
GC Wealth Management RIA, LLC SOLD OUT −4.6M

Who is planning to sell?

Notices of proposed sale, last 12 months

$1.71M

5 notices from 3 people

Shares covered

69.0K

0.95% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Shao-Lee Lin Officer $1.39M
Sumita Ray Officer $318K

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2021–FY2025

+202.8%

+31.91% a year

Each share's claim on the business

−67.0%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$950K vs $40.8M

over 5 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years46% 3–5 years0% 1–3 years3% Under 1 year51%

Quarterly turnover

49.6%

of institutional shares changed hands

Top 10 managers, median time held

0 quarters

Super Investors

Investment managers reporting CUE on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
B Bleichroeder LP	370.7K	5.10%	−6.4M (−94.6%)	≤2021	2.1%
Shares held by quarter Peak holding6.8M (Q2'25) Change over 8 quarters−4.6M Share of the company5.100% Bleichroeder LP's full portfolio →
GW GC Wealth Management RIA, LLC	—	—	SOLD OUT	—	0.0%
Shares held by quarter Peak holding4.6M (Q4'25) Change over 8 quarters0 GC Wealth Management RIA, LLC's full portfolio →

Bleichroeder LP

370.7K

% of company

5.10%

Change vs last qtr

−6.4M (−94.6%)

Held since

≤2021

GC Wealth Management RIA, LLC

—

% of company

—

Change vs last qtr

SOLD OUT

Held since

—

28 more super investors behind a free account

See every manager holding Cue Biopharma, Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting CUE on Form N-PORT; together they hold 2.9% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
VT Vanguard Total Stock Market Index Fund Vanguard Index Funds	$3.53M	111.9K	1.54%	0.00%	June 30, 2026
VE Vanguard Extended Market Index Fund Vanguard Index Funds	$1.49M	47.1K	0.65%	0.00%	June 30, 2026

Vanguard Total Stock Market Index Fund

Vanguard Index Funds

Position value

$3.53M

% of company

1.54%

% of the fund

0.00%

As of

June 30, 2026

Vanguard Extended Market Index Fund

Vanguard Index Funds

Position value

$1.49M

% of company

0.65%

% of the fund

0.00%

As of

June 30, 2026

14 more funds behind a free account

See every fund holding Cue Biopharma, Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
SL Shao-Lee Lin 5%+ holder 13D · 6.2%	467.2K	6.43%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company6.430% Disclosed stake13D · 6.2% View the 13D/G filing →
RS Ray Sumita Insider	116.7K	1.61%	—	—	—	—
Insider holdings come from Form 3/4/5 filings, which are not quarterly. Share of the company1.610% Ray Sumita's insider activity →

Shao-Lee Lin

5%+ holder13D · 6.2%

467.2K

% of company

6.43%

Change vs last qtr

—

Held since

—

Ray Sumita

Insider

116.7K

% of company

1.61%

Change vs last qtr

—

Held since

—

8 more holders behind a free account

See every insider and 5%+ holder of Cue Biopharma, Inc..

Comments